Pricing of Drugs with Evidence Development

Michael K. Gusmano; David Chinitz; Victor Rodwin

doi:10.1001/jama.2022.11232

Pricing of Drugs with Evidence Development

Michael K. Gusmano, David Chinitz, Victor Rodwin

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	777-778
Number of pages	2
Journal	JAMA
Volume	328
Issue number	8
DOIs	https://doi.org/10.1001/jama.2022.11232
State	Published - Aug 23 2022

ASJC Scopus subject areas

General Medicine

Access to Document

10.1001/jama.2022.11232

Cite this

@article{331ca83f852b42eea736378366d76375,

title = "Pricing of Drugs with Evidence Development",

author = "Gusmano, {Michael K.} and David Chinitz and Victor Rodwin",

note = "Funding Information: Conflict of Interest Disclosures: Dr Robinson reported receiving grants from the Laura and John Arnold Foundation, receiving personal fees from Novartis Pharmaceuticals and the St Louis Area Business Healthcare Coalition, serving on the advisory board for the National Institute for Health Care Management, and receiving consulting fees from the Commonwealth Fund. Funding Information: Conflict of Interest Disclosures: Dr Ramnarayan reported receiving personal fees from Fisher & Paykel. Ms Thomas reported receiving grants from the UK National Institute for Health Research. Mr Mouncey reported receiving grants from the National Institute for Health Research{\textquoteright}s Health Technology Assessment program. 1. Ramnarayan P, Richards-Belle A, Drikite L, et al; FIRST-ABC Step-Down RCT Investigators and the Paediatric Critical Care Society Study Group. Effect of high-flow nasal cannula therapy vs continuous positive airway pressure following extubation on liberation from respiratory support in critically ill children: a randomized clinical trial. JAMA. 2022;327(16):1555-1565. doi:10. 1001/jama.2022.3367 2. Uchiyama A, Okazaki K, Kondo M, et al; Non-Invasive Procedure for Premature Neonates (NIPPN) Study Group. Randomized controlled trial of high-flow nasal cannula in preterm infants after extubation. Pediatrics.2020; 146(6):e20201101. doi:10.1542/peds.2020-1101 3. Roberts CT, Owen LS, Manley BJ, et al; HIPSTER Trial Investigators. Nasal high-flow therapy for primary respiratory support in preterm infants. N Engl J Med. 2016;375(12):1142-1151. doi:10.1056/NEJMoa1603694",

year = "2022",

month = aug,

day = "23",

doi = "10.1001/jama.2022.11232",

language = "English (US)",

volume = "328",

pages = "777--778",

journal = "JAMA",

issn = "0098-7484",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Pricing of Drugs with Evidence Development

AU - Gusmano, Michael K.

AU - Chinitz, David

AU - Rodwin, Victor

N1 - Funding Information: Conflict of Interest Disclosures: Dr Robinson reported receiving grants from the Laura and John Arnold Foundation, receiving personal fees from Novartis Pharmaceuticals and the St Louis Area Business Healthcare Coalition, serving on the advisory board for the National Institute for Health Care Management, and receiving consulting fees from the Commonwealth Fund. Funding Information: Conflict of Interest Disclosures: Dr Ramnarayan reported receiving personal fees from Fisher & Paykel. Ms Thomas reported receiving grants from the UK National Institute for Health Research. Mr Mouncey reported receiving grants from the National Institute for Health Research’s Health Technology Assessment program. 1. Ramnarayan P, Richards-Belle A, Drikite L, et al; FIRST-ABC Step-Down RCT Investigators and the Paediatric Critical Care Society Study Group. Effect of high-flow nasal cannula therapy vs continuous positive airway pressure following extubation on liberation from respiratory support in critically ill children: a randomized clinical trial. JAMA. 2022;327(16):1555-1565. doi:10. 1001/jama.2022.3367 2. Uchiyama A, Okazaki K, Kondo M, et al; Non-Invasive Procedure for Premature Neonates (NIPPN) Study Group. Randomized controlled trial of high-flow nasal cannula in preterm infants after extubation. Pediatrics.2020; 146(6):e20201101. doi:10.1542/peds.2020-1101 3. Roberts CT, Owen LS, Manley BJ, et al; HIPSTER Trial Investigators. Nasal high-flow therapy for primary respiratory support in preterm infants. N Engl J Med. 2016;375(12):1142-1151. doi:10.1056/NEJMoa1603694

PY - 2022/8/23

Y1 - 2022/8/23

UR - http://www.scopus.com/inward/record.url?scp=85137124267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137124267&partnerID=8YFLogxK

U2 - 10.1001/jama.2022.11232

DO - 10.1001/jama.2022.11232

M3 - Letter

C2 - 35997742

AN - SCOPUS:85137124267

SN - 0098-7484

VL - 328

SP - 777

EP - 778

JO - JAMA

JF - JAMA

IS - 8

ER -

Pricing of Drugs with Evidence Development

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this